These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2592 related items for PubMed ID: 17418153

  • 1. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U, Even-Sapir E.
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [Abstract] [Full Text] [Related]

  • 2. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance.
    Israel O, Yefremov N, Bar-Shalom R, Kagana O, Frenkel A, Keidar Z, Fischer D.
    J Nucl Med; 2005 May; 46(5):758-62. PubMed ID: 15872347
    [Abstract] [Full Text] [Related]

  • 3. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M.
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [Abstract] [Full Text] [Related]

  • 4. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G.
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [Abstract] [Full Text] [Related]

  • 5. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M, Jiang X, Zhang M, Xu H, Zhai G, Li B.
    J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
    [Abstract] [Full Text] [Related]

  • 6. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
    Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Collins DA, Kasperbauer JL, Strome SE, Reading CC, Hay ID, Lowe VJ.
    Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887
    [Abstract] [Full Text] [Related]

  • 7. Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence.
    Metser U, Miller E, Lerman H, Even-Sapir E.
    AJR Am J Roentgenol; 2007 Nov; 189(5):1203-10. PubMed ID: 17954662
    [Abstract] [Full Text] [Related]

  • 8. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A, Kalinyak JE, McDougall IR.
    Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
    [Abstract] [Full Text] [Related]

  • 9. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
    Du Y, Cullum I, Illidge TM, Ell PJ.
    J Clin Oncol; 2007 Aug 10; 25(23):3440-7. PubMed ID: 17592153
    [Abstract] [Full Text] [Related]

  • 10. F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas.
    Iagaru A, Quon A, McDougall IR, Gambhir SS.
    Clin Nucl Med; 2006 Dec 10; 31(12):754-60. PubMed ID: 17117068
    [Abstract] [Full Text] [Related]

  • 11. (18)F-FDG-PET/CT of orofacial tumors, a value of whole-body imaging approach.
    Ferda J, Ferdová E, Záhlava J, Walter J, Mukensnabl P, Daum O, Kreuzberg B.
    Eur J Radiol; 2010 Feb 10; 73(2):241-8. PubMed ID: 19101104
    [Abstract] [Full Text] [Related]

  • 12. Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions.
    Shammas A, Lim R, Charron M.
    Radiographics; 2009 Feb 10; 29(5):1467-86. PubMed ID: 19755606
    [Abstract] [Full Text] [Related]

  • 13. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ, Zhang YX, Wei H, Jia Q.
    Zhonghua Yi Xue Za Zhi; 2007 Aug 28; 87(32):2253-6. PubMed ID: 18001544
    [Abstract] [Full Text] [Related]

  • 14. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
    Wykrzykowska J, Lehman S, Williams G, Parker JA, Palmer MR, Varkey S, Kolodny G, Laham R.
    J Nucl Med; 2009 Apr 28; 50(4):563-8. PubMed ID: 19289431
    [Abstract] [Full Text] [Related]

  • 15. Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care.
    Israel O, Kuten A.
    J Nucl Med; 2007 Jan 28; 48 Suppl 1():28S-35S. PubMed ID: 17204718
    [Abstract] [Full Text] [Related]

  • 16. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.
    Ann Surg; 2007 Dec 28; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [Abstract] [Full Text] [Related]

  • 17. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
    Pelosi E, Pennone M, Deandreis D, Douroukas A, Mancini M, Bisi G.
    Q J Nucl Med Mol Imaging; 2006 Mar 28; 50(1):15-22. PubMed ID: 16557200
    [Abstract] [Full Text] [Related]

  • 18. Fever of unknown origin: the role of 18F-FDG PET/CT.
    Keidar Z, Gurman-Balbir A, Gaitini D, Israel O.
    J Nucl Med; 2008 Dec 28; 49(12):1980-5. PubMed ID: 18997040
    [Abstract] [Full Text] [Related]

  • 19. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.
    Even-Sapir E, Metser U, Flusser G, Zuriel L, Kollender Y, Lerman H, Lievshitz G, Ron I, Mishani E.
    J Nucl Med; 2004 Feb 28; 45(2):272-8. PubMed ID: 14960647
    [Abstract] [Full Text] [Related]

  • 20. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
    Park JW, Kim JH, Kim SK, Kang KW, Park KW, Choi JI, Lee WJ, Kim CM, Nam BH.
    J Nucl Med; 2008 Dec 28; 49(12):1912-21. PubMed ID: 18997056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 130.